Add Tribune As Your Trusted Source
TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My Money
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill ViewBenchmark
Don't Miss
Advertisement

India leads move to lower vaccine prices

Pak, Nepal back WTO plan co-sponsored by India, South Africa

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Sandeep Dikshit

Advertisement

Tribune News Service

Advertisement

New Delhi, November 22

The Indian approach to lowering Covid vaccine prices has found support from Pakistan as well as all other neighbours, but China has sought time to study it further.

A meeting of a WTO panel on Friday witnessed Pakistan, Kenya, Mozambique and Eswatini joining the India-South Africa proposal for suspending patents and other intellectual property (IP) restrictions on Covid vaccines, drugs and diagnostics for the duration of the pandemic, until global herd immunity is achieved.

Advertisement

China has welcomed the proposal but India’s global security partners such as the US and EU as well as their pharmaceutical corporations have not shown any willingness to take a different approach during the pandemic to ensure broad access to needed products, said sources. India is engaged in a consensus-building exercise in the run-up to a decision towards the middle of next month. Faced with opposition from the US, EU and Brazil, the proposal was put off when it was first tabled at WTO, with support from the WHO, on October 2.

Advertisement
Show comments
Advertisement